Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2026)

Replimune (REPL) reported Change in Acquisitions & Divestments of $90.5 million for Q1 2026, up 39.03% on a YoY basis from $65.1 million in Q1 2025, and down 11.11% sequentially from $101.8 million in Q4 2025.

Replimune (REPL) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Replimune (REPL) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $90.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 39.03% year-over-year to $90.5 million; the trailing twelve-month figure through Mar 2026 stood at $393.0 million (up 1.68% YoY), and the FY2026 full-year result was $393.0 million, up 1.68% from the prior year.
  • Change in Acquisitions & Divestments retreated to $90.5 million in Q1 2026, from $101.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $177.1 million in Q2 2023 to a low of $60.0 million in Q1 2022.
  • A 5-year average of $110.3 million and a median of $105.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments soared 164.39% in 2023 and sank 51.2% in 2025, its largest moves.
  • Tracing REPL's Change in Acquisitions & Divestments over 5 years: stood at $115.7 million in 2022, then surged by 34.46% to $155.5 million in 2023, then tumbled by 40.53% to $92.5 million in 2024, then grew by 10.02% to $101.8 million in 2025, then retreated by 11.11% to $90.5 million in 2026.
  • Business Quant data shows REPL's Change in Acquisitions & Divestments at $90.5 million in Q1 2026, $101.8 million in Q4 2025, and $95.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Replimune 970.73 Mn 970.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 90.46 Mn
Mar 31, 2026 90.46 Mn
Dec 31, 2025 101.77 Mn
Dec 31, 2025 101.77 Mn
Sep 30, 2025 95.36 Mn
Sep 30, 2025 95.36 Mn
Jun 30, 2025 105.37 Mn
Jun 30, 2025 105.37 Mn
Mar 31, 2025 65.07 Mn
Mar 31, 2025 65.07 Mn
Dec 31, 2024 92.50 Mn
Dec 31, 2024 92.50 Mn
Sep 30, 2024 92.00 Mn
Sep 30, 2024 92.00 Mn
Jun 30, 2024 136.91 Mn
Jun 30, 2024 136.91 Mn
Mar 31, 2024 133.34 Mn
Mar 31, 2024 133.34 Mn
Dec 31, 2023 155.54 Mn
Dec 31, 2023 155.54 Mn